D
Crinetics Pharmaceuticals, Inc. CRNX
$34.47 -$0.57-1.63%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024
Revenue -- --
Total Other Revenue -- --
Total Revenue -- --
Cost of Revenue 7.53% 6.10%
Gross Profit -7.53% -6.83%
SG&A Expenses 8.83% 4.24%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses 7.91% 5.55%
Operating Income -7.91% -6.06%
Income Before Tax -4.90% -3.74%
Income Tax Expenses -- --
Earnings from Continuing Operations -4.90% -3.74%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income -4.90% -3.74%
EBIT -7.91% -6.06%
EBITDA -7.96% -6.09%
EPS Basic 8.17% -2.35%
Normalized Basic EPS 8.17% -2.34%
EPS Diluted 8.17% -2.35%
Normalized Diluted EPS 8.17% -2.34%
Average Basic Shares Outstanding 14.24% 1.37%
Average Diluted Shares Outstanding 14.24% 1.37%
Dividend Per Share -- --
Payout Ratio -- --
Weiss Ratings